輸入代號或公司名稱後按 Enter
4173

久裕

+0.10 (+0.58%)最後更新 2026-09-11
台灣 · 上櫃 · 生技醫療業
17.208成交張數21.50本益比0.68股價淨值比6.05%殖利率2026-09-11資料日期

每股盈餘

柱為單季 EPS,線為近四季合計;近十年

季度單季 EPS年增近四季 EPS歸屬母公司淨利(億)淨利率ROE(季)ROE(近四季)
2026Q20.16-60.0%0.800.123.1%0.62%3.12%
2026Q10.26-31.6%1.040.194.7%0.97%4.09%
2025Q40.15-54.5%1.160.122.9%0.59%4.41%
2025Q30.23-37.8%1.340.174.6%0.86%5.19%
2025Q20.4048.1%1.480.307.8%1.56%5.79%
2025Q10.3831.0%1.350.297.3%1.52%5.36%
2024Q40.3313.8%1.260.257.2%1.30%4.76%
2024Q30.3760.9%1.220.288.4%1.46%4.61%
2024Q20.27-3.6%1.080.206.4%1.06%4.24%
2024Q10.2926.1%1.090.216.9%1.09%4.27%
2023Q40.2961.1%1.030.217.5%1.05%3.92%
2023Q30.230.0%0.920.175.8%0.88%3.55%
2023Q20.283.7%0.920.207.0%1.09%3.66%
2023Q10.2343.8%0.910.186.6%0.94%3.74%
2022Q40.18-45.5%0.840.145.3%0.73%3.38%
2022Q30.2391.7%0.990.176.4%0.92%4.10%
2022Q20.2792.9%0.880.208.3%1.10%3.69%
2022Q10.166.7%0.750.124.8%0.68%3.21%
2021Q40.33450.0%0.740.2510.3%1.39%3.07%
2021Q30.121100.0%0.470.093.9%0.51%2.09%
2021Q20.14-51.7%0.360.104.3%0.56%1.85%
2021Q10.15-58.3%0.510.124.7%0.66%2.95%
2020Q40.06-78.3%0.720.062.1%0.36%3.11%
2020Q30.01-95.3%0.940.041.6%0.25%3.68%
2020Q20.29-27.6%1.140.207.3%1.41%4.13%
2020Q10.3612.4%1.250.164.1%1.31%4.97%
2019Q40.2872.2%1.210.144.7%1.09%4.91%
2019Q30.21-29.4%1.090.113.8%0.87%4.56%
2019Q20.4066.7%1.180.208.4%1.62%4.92%
2019Q10.325.9%1.020.165.3%1.30%4.12%
2018Q40.1628.6%1.010.082.3%0.65%4.44%
2018Q30.300.970.154.7%1.29%4.35%
2018Q20.24575.0%0.610.123.8%1.00%2.73%
2018Q10.303300.0%0.400.154.8%1.35%1.75%
2017Q40.12-22.2%0.110.062.0%0.57%0.49%
2017Q3-0.06-200.0%0.14-0.03-1.0%-0.27%0.71%
2017Q20.04-82.6%0.270.020.5%0.15%1.27%
2017Q10.01-91.7%0.440.000.1%0.04%2.08%
2016Q40.160.530.082.5%0.77%
2016Q30.060.030.9%0.28%